Skip to content
healthcare.dev

SOTYKTU

NDC 0003-0895, deucravacitinib, tablet, film coated, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-0895
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214958
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEUCRAVACITINIB6 mg/1

Pharmacologic classes

Tyrosine Kinase 2 Inhibitor [EPC]; Tyrosine Kinase 2 Inhibitors [MoA]

Package NDCNDC-11Package
0003-0895-110000308951130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0895-11)
0003-0895-910000308959130 TABLET, FILM COATED in 1 BLISTER PACK (0003-0895-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ff4d7258-5068-4cdf-9692-8cae04c3198e

Use it

Look up 0003-0895 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0895 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-0895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.